Beneficial effect of graft perfusion with anti-t cell receptor monoclonal antibodies on survival of small bowel allografts in rat recipients treated with brequinar alone or in combination with cyclosporine and sirolimus

Transplantation

Volumn 61, Issue 3, 1996, Pages 458-464

  Wang, Mouer ^a   Qu, Xiumei ^a   Stepkowski, Stanislaw M ^a   Chou, Ting Chao ^a   Kahan, Barry D ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREQUINAR; CYCLOSPORIN; MONOCLONAL ANTIBODY; RAPAMYCIN; T LYMPHOCYTE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HEART TRANSPLANTATION; IMMUNE RESPONSE; INTESTINE GRAFT; MALE; NONHUMAN; ORGAN PERFUSION; PRIORITY JOURNAL; RAT; SMALL INTESTINE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTILYMPHOCYTE SERUM; BIPHENYL COMPOUNDS; CYCLOSPORINE; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; GRAFT VS HOST REACTION; HOST VS GRAFT REACTION; IMMUNE TOLERANCE; IMMUNOSUPPRESSIVE AGENTS; INTESTINE, SMALL; MALE; PERFUSION; POLYENES; RATS; RATS, INBRED ACI; RATS, INBRED BN; RATS, INBRED LEW; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SIROLIMUS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0030021633     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199602150-00025     Document Type: Article

References (30)

1. Grant D. Intestinal transplantation: current status. Transplant Proc 1989; 21: 2869.
2. de Bruin RWF. Small bowel transplantation: an overview. Transpl Int 1994; 7: 47.
3. Grant D, Wall W, Mimeault R, et al. Successful small bowel/liver transplantation. Lancet 1990; 335: 181.
4. Todo S, Tzakis AG, Abu-Elmagd K, et al. Intestinal transplantation in composite visceral grafts or alone. Ann Surg 1992; 216: 223.
5. Fortner JG, Sichuk G, Litwin SD, Beattie EJ. Immunological response to an intestinal allograft with HLA identical donor-recipient. Transplantation 1972; 14: 531.
6. Monchik GJ, Russell PS. Transplantation of small bowel in the rat: technical and immunological considerations. Surgery 1971; 70: 693.
7. Saat RE, deBruin RWF, Heineman E, Jackel J, Marquet RL. The limited efficacy of cyclosporine in preventing rejection and graft-versus-host disease in orthotopic small bowel transplantation in rats. Transplantation 1990; 50: 374.
8. Hoffman AL, Makowka L, Banner B, et al. The use of FK-506 for small intestine allotransplantation. Transplantation 1990; 49: 483.
9. de Bruin RWF, Hogenesch H, Heineman E, Jeekel J, Marquet RL. Fulminant graft-versus-host disease after FK 506 treatment in fully allogeneic small bowel transplantation. Transplant Proc 1991; 23: 3257.
10. Stepkowski SM, Chen HF, Wang ME, Pierre D, Kahan BD. Inhibition of host-versus-graft and graft-versus-host responses after small bowel transplantation in rats by rapamycin. Transplantation 1992; 53: 258.
11. Stepkowski SM, Chen HF, Pierre D, Kahan BD. Rapamycin, a potent immunosuppressive drug for vascularized heart, kidney, and small bowel transplantation in the rat. Transplantation 1991; 51: 22.
12. Fabian MA, Denning SM, Bollinger RR. Rapamycin suppression of host-versus-graft and graft-versus-host disease in MHC-mismatched rats. Transplant Proc 1992; 24: 1174.
13. Chen H, Wu J, Xu D, Aboujaoude M, Stepkowski SM, Kahan BD, Daloze P. The effect of rapamycin on orthotopic small bowel transplantation in the rat. Transplant Proc 1992; 24: 1157.
14. Shaffer D, Maki T, DeMichele SJ, et al. Studies in small bowel transplantation: prevention of graft-versus-host disease with preservation of allograft function by donor pretreatment with antilymphocyte serum. Transplantation 1988; 45: 262.
15. Shaffer D, Ubhi CS, Simpson MA, et al. Prevention of graft-versus-host disease following small bowel transplantation with polyclonal and monoclonal antilymphocyte serum. Transplantation 1991; 52: 948.
16. Lee KKW, Schraut WH. In vitro allograft irradiation prevents graft-versus-host disease in small bowel transplantation. J Surg Res 1985; 38: 258.
17. Saat RE, deBruin RWF, Heineman E, Jackel J, Marquet RL. Irradiation of the donor combined with cyclosporine treatment of the recipient prevents graft-versus-host disease and leads to prolonged survival of small-bowel allografts. Transplant Proc 1990; 22: 2465
18. Johnsson C, Tufveson G. The effects of various routes of administration of monoclonal anti-T cell antibodies for prevention of the graft-versus-host reaction following small bowel transplantation. Transplantation 1994; 57: 289.
19. Smith GJ, Ingham-Clark C, Crane P, et al. Ex vivo perfusion of intestinal allografts with anti-T cell monoclonal antibody/ricin a chain conjugates for the suppression of graft-versus-host disease. Transplantation 1992; 53: 717.
20. Chen SF, Ruben RL, Dexter DL. Mechanism of action of the novel anticancer agent 6-fluoro-2-(2′-fluoro-1,1′-biphenyl-4-yl)-3-methyl-4- quinolinecarboxylic acid sodium salt (NSC 368390): inhibition of de novo pyrimidine nucleotide biosynthesis. Cancer Res 1986; 46: 5014.
21. Cramer DV, Chapman FA, Jaffee BD. The effect of a new immunosuppressive drug, brequinar sodium, on heart, liver, and kidney allograft rejection in the rat. Transplantation 1992; 53: 303.
22. Kahan BD, Tejpal N, Gibbons-Stubbers S, et al. The synergistic interactions in vitro and in vivo of brequinar sodium with cyclosporine or rapamycin alone and in triple combination. Transplantation 1993; 55: 894.
23. Monchik GJ, Russell PS. Transplantation of small bowel in the rat: technical and immunological considerations. Surgery 1971; 70: 693.
24. Ono K, Lindsey ES. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1969; 517: 225.
25. Langrehr JM, Lee KKW, Wachs ME, et al. Comparison of the effectiveness of cyclosporine A in small-bowel transplantation using different rat strain combinations. Transplant Proc 1990; 22: 2533.
26. Stepkowski SM, Kahan BD. Rapamycin and cyclosporine synergistically prolong heart and kidney allograft survival. Transplant Proc 1991; 23: 3262.
27. Tu Y, Stepkowski SM, Chou T-C, Kahan BD. The synergistic effects of cyclosporine, sirolimus, and brequinar on heart allograft survival in mice. Transplantation 1995; 59: 177.
28. Liu J, Farmer JD, Lane WS, Friedman J, Weissman I, Schreiber SL. Calcineurin is a common target of cyclophilin-cyclosporine A and FKBP-FK506 complexes. Cell 1991; 66: 804.
29. Kou CJ, Chong J, Fiorentino DF, et al. Rapamycin selective inhibits interleukin-2 activation of p70S6 kinase. Nature 1992; 358: 70.
30. Knight R, Kurrle R, Stepkowski SM, Serino F, Chou T-C, Kahan BD. Synergistic immunosuppressive actions of cyclosporine with a mouse anti-rat α/β-T cell receptor monoclonal antibody. Transplantation 1994; 57: 1548.